Published in J Am Coll Cardiol on March 15, 2011
The Effect of Yoga on Cardiac Sympathetic Innervation Evaluated by I-123 mIBG | NCT03227393
Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation. N Engl J Med (2015) 10.86
Early safety and efficacy of percutaneous left atrial appendage suture ligation: results from the U.S. transcatheter LAA ligation consortium. J Am Coll Cardiol (2014) 2.94
Atrial-selective inhibition of sodium-channel current by Wenxin Keli is effective in suppressing atrial fibrillation. Heart Rhythm (2011) 2.01
Catheter ablation vs. antiarrhythmic drug treatment of persistent atrial fibrillation: a multicentre, randomized, controlled trial (SARA study). Eur Heart J (2013) 1.83
Rates of hemorrhage during warfarin therapy for atrial fibrillation. CMAJ (2012) 1.68
Age-specific incidence, outcome, cost, and projected future burden of atrial fibrillation-related embolic vascular events: a population-based study. Circulation (2014) 1.53
Lone atrial fibrillation: does it exist? J Am Coll Cardiol (2014) 1.21
Arrhythmia and thyroid dysfunction. Herz (2014) 1.07
2014 AATS guidelines for the prevention and management of perioperative atrial fibrillation and flutter for thoracic surgical procedures. J Thorac Cardiovasc Surg (2014) 0.99
Resolution of a left ventricular thrombus by the thrombolytic action of dabigatran. Heart Vessels (2013) 0.97
Dabigatran and kidney disease: a bad combination. Clin J Am Soc Nephrol (2013) 0.95
EHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: Definition, characterisation, and clinical implication. J Arrhythm (2016) 0.94
Atrial fibrillation: the role of common and rare genetic variants. Eur J Hum Genet (2013) 0.92
The association between mean platelet volume and chronic atrial fibrillation and the presence of thrombotic events. Biomed Rep (2015) 0.90
Warfarin use in hemodialysis patients with atrial fibrillation: decisions based on uncertainty. BMC Nephrol (2013) 0.89
Safe use of antithrombotics for stroke prevention in atrial fibrillation: consideration of risk assessment tools to support decision-making. Ther Adv Drug Saf (2014) 0.89
Left atrial appendage closure to prevent stroke in patients with atrial fibrillation. Circulation (2014) 0.88
Long-term success and follow-up after atrial fibrillation ablation. Curr Cardiol Rev (2012) 0.88
Effects of n-3 Polyunsaturated Fatty Acids on Cardiac Ion Channels. Front Physiol (2012) 0.87
Resolution of left ventricular thrombus secondary to tachycardia-induced heart failure with rivaroxaban. Case Rep Med (2014) 0.87
Clinical considerations of anticoagulation therapy for patients with atrial fibrillation. J Zhejiang Univ Sci B (2012) 0.86
A new era of stroke prevention in atrial fibrillation: comparing a new generation of oral anticoagulants with warfarin. Int Arch Med (2013) 0.86
Atrial-selective sodium channel block strategy to suppress atrial fibrillation: ranolazine versus propafenone. J Pharmacol Exp Ther (2011) 0.86
Atrial fibrillation as a marker of occult cancer. PLoS One (2014) 0.86
Practice Patterns for Outpatients With Stable Coronary Artery Disease: A Case Vignette-based Survey Among French Cardiologists. EBioMedicine (2015) 0.86
Genetic polymorphisms in ZFHX3 are associated with atrial fibrillation in a Chinese Han population. PLoS One (2014) 0.86
An updated review of target-specific oral anticoagulants used in stroke prevention in atrial fibrillation, venous thromboembolic disease, and acute coronary syndromes. J Am Heart Assoc (2013) 0.86
Mechanisms of arrhythmias and conduction disorders in older adults. Clin Geriatr Med (2012) 0.85
The effects of wenxin keli on p-wave dispersion and maintenance of sinus rhythm in patients with paroxysmal atrial fibrillation: a meta-analysis of randomized controlled trials. Evid Based Complement Alternat Med (2013) 0.85
N-Acetylcysteine supplementation for the prevention of atrial fibrillation after cardiac surgery: a meta-analysis of eight randomized controlled trials. BMC Cardiovasc Disord (2012) 0.85
The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism. Eur Thyroid J (2015) 0.84
Novel pharmacological targets for the rhythm control management of atrial fibrillation. Pharmacol Ther (2011) 0.83
Novel oral anticoagulants for stroke prevention in atrial fibrillation: a focus on the older patient. Int J Gen Med (2013) 0.83
The role of transcription factors in atrial fibrillation. J Thorac Dis (2015) 0.82
Upstream therapy with statin and recurrence of atrial fibrillation after electrical cardioversion. Review of the literature and meta-analysis. BMC Cardiovasc Disord (2012) 0.82
Long-range regulatory interactions at the 4q25 atrial fibrillation risk locus involve PITX2c and ENPEP. BMC Biol (2015) 0.82
Lack of association between rs3807989 in cav1 and atrial fibrillation. Int J Clin Exp Pathol (2014) 0.81
Comparison of left versus right atrial myocardium in patients with sinus rhythm or atrial fibrillation - an assessment of mitochondrial function and microRNA expression. Physiol Rep (2014) 0.81
Left Atrial Appendage Function and Stroke Risk. Stroke (2015) 0.80
The role of extracellular matrix in age-related conduction disorders: a forgotten player? J Geriatr Cardiol (2015) 0.80
A novel treatment strategy of new onset atrial fibrillation after cardiac surgery: an observational prospective study. J Cardiothorac Surg (2014) 0.80
Hypertrophic cardiomyopathy: diagnosis, risk stratification and treatment. CMAJ (2012) 0.80
Atrial fibrillation in acute ST-elevation myocardial infarction: clinical and prognostic features. Curr Cardiol Rev (2012) 0.80
Reproducibility and Reliability of the Quality of Life Questionnaire in Patients With Atrial Fibrillation. Arq Bras Cardiol (2016) 0.80
Validation of a decision rule for selective TSH screening in atrial fibrillation. West J Emerg Med (2015) 0.79
A single-center randomized, controlled trial investigating the efficacy of a mHealth ECG technology intervention to improve the detection of atrial fibrillation: the iHEART study protocol. BMC Cardiovasc Disord (2016) 0.79
Warfarin Use and Risk of Stroke in Patients With Atrial Fibrillation Undergoing Hemodialysis: A Meta-Analysis. Medicine (Baltimore) (2016) 0.79
Adjunct ablation strategies for persistent atrial fibrillation-beyond pulmonary vein isolation. J Thorac Dis (2015) 0.79
Does CHA2DS2-VASc improve stroke risk stratification in postmenopausal women with atrial fibrillation? Am J Med (2013) 0.79
Score for atrial fibrillation detection in acute stroke and transient ischemic attack patients in a Brazilian population: the acute stroke atrial fibrillation scoring system. Clinics (Sao Paulo) (2014) 0.79
Gender differences in patients with atrial fibrillation. Herzschrittmacherther Elektrophysiol (2013) 0.79
Costs and clinical consequences of suboptimal atrial fibrillation management. Clinicoecon Outcomes Res (2012) 0.79
Trends in Oral Anticoagulation Therapy Among Korean Patients With Atrial Fibrillation: The KORean Atrial Fibrillation Investigation. Korean Circ J (2012) 0.78
Impacts of patient characteristics on the effectiveness of landiolol in AF/AFL patients complicated with LV dysfunction: Subgroup analysis of the J-Land study. Adv Ther (2014) 0.78
Managing atrial fibrillation. Ann Emerg Med (2015) 0.78
Detecting and monitoring arrhythmia recurrence following catheter ablation of atrial fibrillation. Front Physiol (2015) 0.78
Impact of an Emergency Department Observation Unit Management Algorithm for Atrial Fibrillation. J Am Heart Assoc (2016) 0.78
Meta-analysis of the therapeutic effects of various methods for the treatment of chronic atrial fibrillation. Exp Ther Med (2013) 0.78
Role of neural modulation in the pathophysiology of atrial fibrillation. Indian J Med Res (2014) 0.78
Antiarrhythmic therapy in atrial fibrillation: indications, guidelines, and safety. Tex Heart Inst J (2012) 0.77
AT1 mutations and risk of atrial fibrillation based on genotypes from 71,000 individuals from the general population. Br J Clin Pharmacol (2013) 0.77
Endoplasmic reticulum stress as a novel mechanism in amiodarone-induced destructive thyroiditis. J Clin Endocrinol Metab (2015) 0.77
Newer anticoagulants for non-valvular atrial fibrillation. Pharmaceuticals (Basel) (2012) 0.77
Physician's fear of anticoagulant therapy in nonvalvular atrial fibrillation. Am J Med Sci (2014) 0.77
Incidence of supraventricular arrhythmias during autologous peripheral blood stem cell transplantation. Biol Blood Marrow Transplant (2013) 0.77
Atrial fibrillation: mechanisms, therapeutics, and future directions. Compr Physiol (2015) 0.77
Patterns of warfarin use in subgroups of patients with atrial fibrillation: a cross-sectional analysis of 430 general practices in the United Kingdom. PLoS One (2013) 0.77
Impact of duration and dosage of statin treatment and epicardial fat thickness on the recurrence of atrial fibrillation after electrical cardioversion. Heart Vessels (2014) 0.76
Atrial fibrillation in patients with heart failure: Role of catheter ablation therapies. Exp Clin Cardiol (2012) 0.76
Effects of atorvastatin on atrial remodeling in a rabbit model of atrial fibrillation produced by rapid atrial pacing. BMC Cardiovasc Disord (2016) 0.76
Refractory atrial fibrillation effectively treated with ranolazine. Indian Heart J (2014) 0.76
Carvedilol for prevention of atrial fibrillation after cardiac surgery: a meta-analysis. PLoS One (2014) 0.76
Risk of new-onset atrial fibrillation in elderly patients with the overlap syndrome: a retrospective cohort study. J Geriatr Cardiol (2013) 0.76
Effect of berberine on acetylcholine-induced atrial fibrillation in rabbit. Am J Transl Res (2015) 0.76
Brugada syndrome risk loci seem protective against atrial fibrillation. Eur J Hum Genet (2014) 0.76
Wenxin Keli versus Sotalol for Paroxysmal Atrial Fibrillation Caused by Hyperthyroidism: A Prospective, Open Label, and Randomized Study. Evid Based Complement Alternat Med (2015) 0.76
Atrial fibrillation in heart failure: stroke risk stratification and anticoagulation. Heart Fail Rev (2014) 0.76
Long-Term Overexpression of Hsp70 Does Not Protect against Cardiac Dysfunction and Adverse Remodeling in a MURC Transgenic Mouse Model with Chronic Heart Failure and Atrial Fibrillation. PLoS One (2015) 0.75
Increases in intravenous magnesium use among hospitalized patients: an institution cross-sectional experience. Can J Kidney Health Dis (2015) 0.75
Ranolazine versus amiodarone for prevention of postoperative atrial fibrillation. Future Cardiol (2011) 0.75
QRS duration predicts death and hospitalization among patients with atrial fibrillation irrespective of heart failure: evidence from the AFFIRM study. Europace (2013) 0.75
How does Chronic Atrial Fibrillation Influence Mortality in the Modern Treatment Era? Curr Cardiol Rev (2015) 0.75
Preprocedural imaging for patients with atrial fibrillation and heart failure. Curr Cardiol Rep (2012) 0.75
Coronary artery bypass graft surgery: the past, present, and future of myocardial revascularisation. Surg Res Pract (2014) 0.75
Exclusion of the left atrial appendage to prevent stroke in cases of atrial fibrillation. Tex Heart Inst J (2012) 0.75
Preventive effect of intraoperative landiolol administration on atrial fibrillation after off-pump coronary artery bypass grafting. Adv Ther (2014) 0.75
Healthcare utilization and costs for patients initiating Dabigatran or Warfarin. Health Qual Life Outcomes (2017) 0.75
Percutaneous Left Atrial Appendage Ligation for Stroke Prevention in Atrial Fibrillation. Methodist Debakey Cardiovasc J (2015) 0.75
Developing a New Computer-Aided Clinical Decision Support System for Prediction of Successful Postcardioversion Patients with Persistent Atrial Fibrillation. Comput Math Methods Med (2015) 0.75
Association of hemostatic markers with atrial fibrillation: a meta-analysis and meta-regression. PLoS One (2015) 0.75
Staged hybrid ablation for persistent and longstanding persistent atrial fibrillation effectively restores sinus rhythm in long-term observation. Arch Med Sci (2016) 0.75
Effects of pharmacologic therapy on health-related quality of life in elderly patients with atrial fibrillation: a systematic review of randomized and nonrandomized trials. Clin Med Insights Cardiol (2013) 0.75
A review on atrioventricular junction ablation and pacing for heart rate control of atrial fibrillation. J Geriatr Cardiol (2015) 0.75
Postoperative atrial fibrillation in patients undergoing non-cardiac non-thoracic surgery: A practical approach for the hospitalist. Hosp Pract (1995) (2015) 0.75
Genetic risk for atrial fibrillation could motivate patient adherence to warfarin therapy: a cost effectiveness analysis. BMC Cardiovasc Disord (2015) 0.75
The use status of anticoagulation drugs for inpatients with nonvalvular atrial fibrillation in Southwest China. Int J Gen Med (2017) 0.75
Untreated atrial fibrillation in the United States of America: Understanding the barriers and treatment options. J Saudi Heart Assoc (2014) 0.75
Atrial fibrillation care improvement collaborative. BMJ Qual Improv Rep (2015) 0.75
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med (2011) 28.99
2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2013) 12.73
Strategies for multivessel revascularization in patients with diabetes. N Engl J Med (2012) 10.79
2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation (2013) 10.24
Basal insulin and cardiovascular and other outcomes in dysglycemia. N Engl J Med (2012) 10.09
2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol (2014) 9.96
2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J (2013) 9.54
Dronedarone in high-risk permanent atrial fibrillation. N Engl J Med (2011) 8.93
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2012) 7.94
Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med (2013) 7.70
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2010) 7.54
A pharmacogenetic versus a clinical algorithm for warfarin dosing. N Engl J Med (2013) 7.09
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation (2012) 6.94
n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia. N Engl J Med (2012) 6.16
Long-term air pollution exposure and acceleration of atherosclerosis and vascular inflammation in an animal model. JAMA (2005) 5.83
Atherosclerosis across 4000 years of human history: the Horus study of four ancient populations. Lancet (2013) 5.61
2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation (2013) 5.02
The MOGE(S) classification for a phenotype-genotype nomenclature of cardiomyopathy: endorsed by the World Heart Federation. J Am Coll Cardiol (2013) 4.81
Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial. Lancet (2011) 4.67
ACC/AHA 2002 guideline update for exercise testing: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). J Am Coll Cardiol (2002) 4.48
Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation. Eur Heart J (2005) 4.46